Llwytho...
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
In France, the incidence of invasive meningococcal disease (IMD) is around 1/100,000, with the following trends over the 2011–2018 period: a leading role of group B in subjects <15 years, a decrease of group C among <1 year since 2017, an increase of group W in all age groups including subject...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hum Vaccin Immunother |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7644201/ https://ncbi.nlm.nih.gov/pubmed/32209010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1729030 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|